Understanding the biological activities of cysteine-rich peptides from Acanthopanax trifoliatus
Acanthopanax Trifoliatus (A.trifoliatus) is a traditional Chinese medicinal herb with antioxidant, anti-inflammatory, and anticancer properties. In this study, we characterised the biological activities of acantide aT1, the first cysteine-rich peptide (CRP) from A.trifoliatus, which shares sequen...
Saved in:
Main Author: | |
---|---|
Other Authors: | |
Format: | Final Year Project |
Language: | English |
Published: |
Nanyang Technological University
2023
|
Subjects: | |
Online Access: | https://hdl.handle.net/10356/166908 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Nanyang Technological University |
Language: | English |
Summary: | Acanthopanax Trifoliatus (A.trifoliatus) is a traditional Chinese medicinal herb with
antioxidant, anti-inflammatory, and anticancer properties. In this study, we
characterised the biological activities of acantide aT1, the first cysteine-rich peptide
(CRP) from A.trifoliatus, which shares sequence homology with ginsentides (from
ginseng). Acantide aT1 has an eight-cysteine motif: CXnCXnCCXnCXnCXnCXnC,
typical of the newly discovered family, ginsentide-like peptide also named as non-
chitin-binding-eight-cysteine-hevein-like peptide (NCB-8C-HLP). Confocal
microscopy revealed that acantide aT1 is a cell-penetrating peptide. Using affinity
selection mass spectrometry, we then identified an intracellular target of aT1, protein
phosphatase 2A (PP2A). Ser/Thr Phosphatase assay confirms that acantide aT1
inhibits PP2A activities. Using TMT-based quantitative proteomics, we showed that,
among the top 19 enriched pathways, approximately 30% of them have an
association with phosphatase activity and one of the downstream pathways of PP2A,
ERK cascade was also enriched. Western blot analysis confirms that acantide aT1
upregulates the expression of p-MEK, p-ERK and its downstream proteins. MTT
assay also indicates that aT1 promotes cell proliferation without cytotoxicity. These
findings suggest that acantide aT1 holds exceptionally high promise as a therapeutic
for cancer and cardiovascular diseases given its uncommon combinations of being a
35-residue naturally-occurring and cell-penetrating peptide which targets and inhibits
PP2A. |
---|